ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
3 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
171
|
49K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mxdbg
|
56 |
15K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
56
|
15K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mxdbg
|
56 |
15K |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
56
|
15K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mxdbg
|
56 |
15K |
4 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
56
|
15K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
2 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
9 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
9
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
4 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
3 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
472
|
182K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
0 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
472
|
182K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
12 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
472
|
182K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
3 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
472
|
182K
|
3
|
|
General
|
|
Re:
<: Crack It :--->
|
|
mxdbg
|
13 |
2.7K |
0 |
17/06/22 |
17/06/22 |
General
|
13
|
2.7K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
2 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
472
|
182K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
8 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
472
|
182K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
7 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
153
|
57K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
8 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
153
|
57K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
6 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
153
|
57K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
7 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
472
|
182K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
13 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
472
|
182K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
27 |
11/06/22 |
11/06/22 |
ASX - By Stock
|
472
|
182K
|
27
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
4 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
472
|
182K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
6 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
472
|
182K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
9 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
472
|
182K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
20 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
153
|
57K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
153
|
57K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
153
|
57K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
5 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
153
|
57K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
mxdbg
|
153 |
57K |
5 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
153
|
57K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
mxdbg
|
35 |
15K |
0 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
35
|
15K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
mxdbg
|
35 |
15K |
9 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
35
|
15K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
5 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
2 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
mxdbg
|
35 |
15K |
5 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
35
|
15K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
mxdbg
|
35 |
15K |
2 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
35
|
15K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
mxdbg
|
35 |
15K |
13 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
35
|
15K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
9 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
9
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
8 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
12 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
472
|
182K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
2 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
472
|
182K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
mxdbg
|
472 |
182K |
4 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
472
|
182K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
5 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
7 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
4 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
FDA application made for fast track for COVID-19
|
|
mxdbg
|
275 |
96K |
0 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
275
|
96K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
FDA application made for fast track for COVID-19
|
|
mxdbg
|
275 |
96K |
2 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
275
|
96K
|
2
|
|